• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

Threadneedle UK Equity Income Fund L Gross Accumulation GBP (Restricted Fund)

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider Threadneedle Investment Services Ltd
Fund Summary The Fund aims to provide income combined with prospects for investment growth over the long term. It looks to provide an income yield higher than the FTSE All-Share Index over rolling 3-year periods, after the deduction of charges. The Fund is actively managed, and invests at least 90% of its assets in the shares of companies listed on the London Stock Exchange; predominantly UK companies.
SEDOL code BDZYJT9
ISIN GB00BDZYJT97
Fund code THUEA
Managers Richard Colwell
Manager Tenure 10 years
Morningstar Category UK Equity Income
IMA Sector UK Equity Income
Fund Size £2,147 million
Fund Type OEIC
Management Style Active
Ongoing Charge Figure (OCF) 0.6%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £2.7382
Buy Price £2.7382
Price Change +2.4201%
Price Date 23rd September 2020
Yield 4.08%
Dividend Frequency Quarterly
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 6th April 2020
Fund Status OPEN
Richard Colwell is a portfolio manager and Head of UK Equities at Columbia Threadneedle. He manages the Threadneedle UK Growth & Income Fund, Threadneedle UK Equity Income Fund and the Threadneedle UK Equity Alpha Income Fund. He also co-manages the Threadneedle Monthly Extra Income Fund and has research responsibility across all sectors. Before joining the company, Richard ran high alpha UK equity portfolios at Aviva Investors. He has also held portfolio management roles at Credit Suisse and Schroders and worked at the Bank of England. Richard has a degree in Banking, Insurance & Finance from the University of Bangor. He holds the Chartered Financial Analyst designation and is a member of the CFA Society of the UK as well as the Chartered Institute of Bankers.

3-year Mean Monthly Return: -0.052%

Annual Returns 2019 2018 2017
Fund Performance -8.04% -3.29% +5.93%
Benchmark Performance
(UK Equity Income)
-14.88% -2.76% +5.09%
Time Period Cumulative Benchmark Performance
(UK Equity Income)
Fund Compared to Benchmark
1 day 2.42% -21.91% +24.33%
1 week -1.72% -1.45% -0.26%
1 month 0.39% -4.41% +4.80%
3 months -1.99% +22.15% -24.14%
6 months 26.11% -16.24% +42.35%
1 year -10.97% -4.61% -6.37%
3 years -1.60% -5.05% +3.45%
5 years Currently unavailable Currently unavailable Currently unavailable
10 years Currently unavailable Currently unavailable Currently unavailable
YTD -16.25% -2.48% -13.77%
Since inception -1.73% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
AstraZeneca PLC GBR 10.92%
GlaxoSmithKline PLC GBR 7.30%
Rentokil Initial PLC GBR 5.44%
Electrocomponents PLC GBR 5.33%
Imperial Brands PLC GBR 4.57%
Phoenix Group Holdings PLC GBR 4.04%
Unilever PLC GBR 3.96%
Morrison (Wm) Supermarkets PLC GBR 3.95%
RSA Insurance Group PLC GBR 3.50%
3i Ord GBR 2.97%
Dividend Date Per share amount Reinvestment Price
8th September 2020 0.0235 £2.7190
8th June 2020 0.0213 £2.8148
6th March 2020 0.0285 £2.8965
9th December 2019 0.0306 £3.1295
6th September 2019 0.0324 £3.0670
10th June 2019 0.0406 £2.9327